← Back to Search

Dyspnea Intervention for Lung Cancer

N/A
Waitlist Available
Led By Joseph Greer, PhD
Research Sponsored by Massachusetts General Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 24 weeks
Awards & highlights

Study Summary

This trial is testing a new way to help people with lung cancer manage their shortness of breath.

Eligible Conditions
  • Lung Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~24 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 24 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Secondary outcome measures
Activity Level (objective measures)
Other outcome measures
Activity Level (self-report: Godin-Shephard Leisure Time Physical Activity Questionnaire)
Cancer Dyspnoea Scale (CDS)
Examine potential mediators of intervention effects on patient-reported outcomes
+5 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Dyspnea InterventionExperimental Treatment2 Interventions
Dyspnea intervention will be administered over two sessions Patients will receive: Psychoeducation Relaxation training for reducing physiological stress Behavioral techniques for managing acute breathlessness
Group II: Usual CareActive Control1 Intervention
Patients will receive any usual care for their dyspnea as deemed appropriate by their clinicians.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Dyspnea Intervention
2017
N/A
~250

Find a Location

Who is running the clinical trial?

Massachusetts General HospitalLead Sponsor
2,925 Previous Clinical Trials
13,197,654 Total Patients Enrolled
Joseph Greer, PhDPrincipal InvestigatorMassachusetts General Hospital
1 Previous Clinical Trials
49 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Brief Behavioral Intervention for Dyspnea in Patients With Advanced Lung Cancer
Joseph A. Greer, Ph.D. 2017. "Brief Behavioral Intervention for Dyspnea in Patients With Advanced Lung Cancer". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03089125.
~32 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top